Cite
HARVARD Citation
Klein-González, N. et al. (n.d.). P09.05 Immunogenicity induced by the academic chimeric antigen receptor CAR19 (ARI-0001) in patients with CD19-positive relapsed/refractory B-cell malignancies recruited into the CART19-BE-01 clinical trial. Journal for immunotherapy of cancer. p. A54. [Online].